Rights and permissions
About this article
Cite this article
UK NICE has issued final guidance to the NHS recommending against the use of bevacizumab. Pharmacoecon. Outcomes News 619, 4 (2011). https://doi.org/10.2165/00151234-201106190-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106190-00013